Trials / Not Yet Recruiting
Not Yet RecruitingNCT06922773
Between the Belly and the Brain: Distorted Gut-brain Crosstalk in Early-life Adversity
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Universitair Ziekenhuis Brussel · Academic / Other
- Sex
- All
- Age
- 6 Years – 13 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn about the effects of early-life adversity (ELA) on the composition of children's microbiome and on their psychosocial functioning. The main questions it aims to answer are: * Do children who have experienced ELA have lower gut microbial diversity and/or an altered gut microbial composition? * Do these microbiome alterations correlate with adverse neurodevelopmental outcomes, including increased levels of stress, social and/or affective problems?
Conditions
- Early Life Adversity
- Microbiome, Human
- Anxiety Symptoms
- Depressive Symptoms
- Posttraumatic Stress Symptoms
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Completion of questionnaires; child psychiatric screening; faecal sample analysis | Completion of questionnaires: * FFQ (Food Frequency Questionnaire) - completed by child * KIDSCREEN-10 - completed by child * CRIES-13 (Child Revised Impact of Events Scale) - completed by parents/guardian and child * CTES (Childhood Trust Events Survey) - completed by parents/guardian * RCADS-25 (Revised Children's Anxiety and Depression Scale) - completed by parents/guardian and child Child psychiatric screening using SCID-5-Junior - semi-structured interview conducted with child and parent(s)/guardian Faecal sample analysis: * Beta-diversity (UniFrac and Bray-Curtis distance index) * Firmicutes/Bacteroidetes ratio * Abundance of Prevotella, Lactobacillaceae, Bifidobacteriacae and Lachnospiraceae * Short-chain fatty acid metabolites |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2026-04-01
- Completion
- 2026-06-01
- First posted
- 2025-04-10
- Last updated
- 2025-04-10
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT06922773. Inclusion in this directory is not an endorsement.